Alloimmunization following antigen-negative red blood cell transfusion

Area of Science:

• Transfusion Medicine
• Immunology
• Hematology

Background:

• Red blood cell (RBC) alloimmunization is common in patients with hemoglobinopathies and myeloid neoplasms.
• Alloimmunization typically requires prior antigen exposure, but natural antibodies or re-emergence after stimulation can occur.
• Rarely, alloantibodies may appear without a known stimulus.

Observation:

• Two cases of de novo RBC alloimmunization (anti-E and anti-K) were observed.
• One case demonstrated the re-emergence of a previously evanescent anti-K alloantibody.
• These events occurred despite transfusions with RBCs negative for the corresponding antigens.

Findings:

• The study presents cases of seemingly spontaneous RBC alloimmunization and alloantibody re-emergence.
• These phenomena occurred in the context of standard transfusion testing and procedures.
• The exact mechanisms for these unexpected alloantibody developments remain unclear.

Implications:

• These findings underscore the immunogenic potential of RBC transfusions.
• The study highlights the importance of identifying alloantibody specificities, even without a clear transfusion history.
• Understanding these unusual alloimmunization pathways is crucial for patient safety and transfusion management.